CAT
Caterpillar Inc.
CAT's fundamentals are strong, but it looks expensive: trading at 24x earnings, above its usual 18x. Analysts expect strong earnings growth, though they disagree widely on how much.
CRESY
Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria
There isn't enough reported data to score CRESY yet.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
CRESY Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Unavailable | |
| Under pressure |
CRESY's profitability is currently strong, but its balance sheet is under pressure. There isn't enough data to rate its revenue and cash flow.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over CRESY in the historical PE scenario, which offers more potential upside but is not a forecast.
CRESY PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 9.1x | $8.95 | — |
| Cheap | 9.5x | $0.95 | -89% |
| Fair | 11x | $1.05 | -88% |
| Expensive | 11x | $1.13 | -87% |
Historical ranges are pointers, not guarantees.
CRESY's PE is 9.1x, but its earnings don't support one, so it isn't a reliable read right now.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
CRESY Forward outlook
There aren't enough analyst estimates for CRESY to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over CRESY in the latest year-over-year earnings comparison.
CRESY Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2025 | $0.10 | +25% |
| Q2 2024 | $0.08 | -90% |
| Q2 2023 | $0.82 | +257% |
CRESY earned $0.10 per share over the past year, down 23% from the year before.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CRESY has the stronger quarterly revenue trend. Revenue is up 17% for CAT versus up 804% for CRESY.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT's operating margin was 20% last quarter, up 3.1 points from the same quarter a year ago.
CRESY Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $591.7M | +29% |
| Q2 2024 | $460.4M | +790% |
| Q1 2023 | $71.1M | +250% |
| Q4 2022 | $65.4M | +205% |
| Q3 2022 | $46.1M | +126% |
| Q2 2021 | $27.5M | -65% |
| Q2 2020 | $78.5M | +47% |
| Q2 2019 | $53.5M | +112% |
CRESY's revenue has grown year over year for six quarters in a row: $592M last quarter, up 804% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | 32% | +82 points |
| Q2 2024 | 4.5% | +6.8 points |
| Q2 2023 | -2.9% | N/A |
| Q1 2023 | 9.1% | +200 points |
| Q4 2022 | -50% | -268 points |
| Q3 2022 | -2.3% | +14 points |
| Q1 2022 | -191% | -227 points |
| Q4 2021 | 218% | +230 points |
CRESY's operating margin was 32% last quarter, up 82 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CRESY has the stronger cash trend. Its trailing FCF is up 2,658% versus its history, compared with CAT at up 39%.
CRESY Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | $68.3M | +$74.7M |
| Q2 2024 | -$6.3M | -146% |
| Q2 2023 | $13.9M | +780% |
| Q1 2023 | $5.3M | +$6M |
| Q4 2022 | -$21.1M | -2634% |
| Q3 2022 | $5.7M | -41% |
| Q2 2017 | $1.3M | +126% |
CRESY's free cash flow has turned positive again: $81M over the past year, against −$14M the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over CRESY on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
CRESY Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3% | +18.2M shares |
| 1 year | +811% | +560M shares |
| 3 years | +1043% | +574M shares |
CRESY has 629M diluted shares, up 811% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2023 | $935,922 |
| Q1 2023 | $9.6M |
| Q4 2022 | $1.6M |
| Q3 2022 | $2.4M |
| Q2 2022 | $77,023 |
| Q1 2022 | $20,065 |
| Q4 2021 | $3,009 |
| Q3 2021 | $3,009 |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
CRESY Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2025 | 3.2x | Elevated |
| Q2 2024 | 11.0x | High |
| Q2 2023 | 11.9x | High |
| Q1 2023 | 2.5x | Moderate |
| Q3 2022 | 1.6x | Healthy |
| Q2 2022 | 3.9x | Elevated |
| Q2 2021 | 6.8x | High |
| Q2 2020 | 5.1x | High |
CRESY's net debt is about 3.2 years of its operating earnings (EBITDA), up from 1.6 years a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
CRESY Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.0 | Neutral |
| Stochastic | 9.8 | Oversold |
CRESY's weekly RSI is 33 (neutral) and its Stochastic is 10 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
CRESY PE vs Industrials Sector
| Metric | CRESY | Sector median | Relative |
|---|---|---|---|
| PE | 9.1x | 24x | 62% below |
| PE % | 10 | 58 | 48 pts below |
CRESY has the edge over CAT on valuation relative to its sector.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over CRESY on trend strength, trading above more of its moving averages.
CRESY Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $10.9 | 18% below |
| 20 week MA | $11.2 | 20% below |
| 50 week MA | $11.5 | 22% below |
| 100 week MA | $11.3 | 21% below |
| 200 week MA | $9.70 | 7.7% below |
CRESY is in a downtrend: it's below all five of its weekly moving averages, and 7.7% below its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over CRESY on returns for 2026, with the stronger performance.
CRESY Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $7.05 | $3.82 | -46% |
| 2021 | $3.82 | $4.56 | +19% |
| 2022 | $4.56 | $5.93 | +30% |
| 2023 | $5.93 | $9.40 | +59% |
| 2024 | $9.40 | $12.9 | +37% |
| 2025 | $12.9 | $11.8 | -7.9% |
| 2026 YTD | $11.8 | $8.95 | -24% |
CRESY has finished higher in four of the last six years. It's down 24% so far in 2026.